Application segmentation delineates the end‑use contexts that drive demand for absorbent foam dressings. In the acute wound segment—comprising traumatic injuries, burns, and pressure ulcers—clinical protocols prioritize rapid exudate management, accounting for roughly 45 % of total market volume. The chronic wound segment, which includes diabetic foot ulcers, venous leg ulcers, and arterial ulcers, contributes about 35 %; its growth is anchored in an aging population and rising prevalence of metabolic disorders, prompting longer‑term dressing utilization. The remaining 20 % originates from surgical wound applications, where postoperative dressings are employed to mitigate infection risk and support healing in inpatient settings. Together, these application categories form the core of the Absorbent Foam Dressing segmentation, each influencing overall market size through distinct procurement cycles, reimbursement pathways, and clinical guidelines.